Vancomycin Antibodies

Santa Cruz Biotechnology provides a broad selection of Vancomycin monoclonal antibodies for the detection and analysis of vancomycin, a critical glycopeptide antibiotic. Vancomycin monoclonal antibodies support various research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Vancomycin plays a vital role in treating serious bacterial infections, particularly those caused by Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). Its mechanism of action involves inhibiting cell wall synthesis, making it essential in clinical settings for managing resistant infections. Understanding the dynamics of vancomycin through advanced research methods can provide insights into antibiotic efficacy and resistance patterns. Monitoring vancomycin levels in clinical samples helps optimize therapeutic dosing and patient outcomes. Studying vancomycin interactions with bacterial cell walls advances our knowledge of antimicrobial mechanisms. Research utilizing Vancomycin monoclonal antibodies from Santa Cruz Biotechnology contributes significantly to advancing antibiotic research and combating antimicrobial resistance.